PrProfile: A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ION717

IsraelRecruitingPHASE1, PHASE2

Conditions

Prion Disease

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Massachusetts General Hospital, Boston, Massachusetts, United States

  • NYU Langone Health, New York, New York, United States

  • University Hospitals Cleveland Medical Center, Cleveland, Ohio, United States

  • Royal Melbourne Hospital, Parkville, Australia

  • McGill University Health Centre, Montreal, Quebec, Canada

  • Hôpital Universitaire Pitié Salpêtrière, Paris, France

  • University Medical Center Göttingen, Göttingen, Germany

  • Tel Aviv Sourasky Medical Center, Tel Aviv, Israel

  • Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta, Milan, Italy

  • Mihara Memorial Hospital, Gunma, Isesaki-shi, Japan

  • National Center of Neurology and Psychiatry, Tokyo, Kodaira-shi, Japan

  • Neuromuscular Center Yoshimizu Hospital, Yamaguchi, Shimonoseki-shi, Japan

  • Hospital Clinic De Barcelona, Barcelona, Spain